Affymax, Inc. (AFFY)

[aquaspin]

“ February 2013, the FDA had received 19 reports of severe anaphylactic reactions occurring within 30 min of a patient’s first dose. Indeed, among 19,428 patients who received intravenous peginesatide in a postapproval study, there were seven deaths due to anaphylaxis. The cause of this was not clear, but the preparation used in preapproval clinical trials was a single-dose vial, whereas the product used in dialysis units in the United States was a multidose vial with preservatives. Regardless, the manufacturer voluntarily withdrew peginesatide from further clinical use, and this drug is no longer available.”

I think AFFY should bring back Peginesatide but in single dose vials. Then we would be north of $20 a share IMO. Seemed like the drug was fine in single dose vials